Alice Lorusso Publishes Study on Optimized Pathogen Reduction for Double-Dose Platelets
Alice Lorusso, Senior Medical Scientist at Irish Blood Transfusion Service, posted on LinkedIn:
”Thrilled to share that my paper “Optimized pathogen reduction of double-dose platelets pooled from seven buffy coats using the TACSI system” has been published in Vox Sanguinis.
This study explores how double-dose platelet components can be safely pathogen-reduced while maintaining excellent in-vitro quality and compliance with EDQM specifications.
Grateful to my co-authors and colleagues for the teamwork and dedication that made this possible ”
Read the full article here.
Title: Optimized pathogen reduction of double-dose platelets pooled from seven buffy coats using the TACSI® system
Authors: Alice Lorusso, Liam Morgan, Aileen Farrelly, Mark Lambert, Barry Doyle, Paul Hendrick, Einas Elsheikh, Andrew Godfrey, Tor Hervig, Allison Waters
Stay updated with Hemostasis Today.
-
Dec 17, 2025, 15:24Laura Dormer on a Motor Relearning Program for Chronic Stroke Patients
-
Dec 17, 2025, 15:01WSO: United Nations Has Formally Adopted the Political Declaration on NCDs and Mental Health
-
Dec 17, 2025, 14:44Bryan Unger: 1st Patient Has Been Enrolled in NuvOx Therapeutics’ Phase IIb NOVEL Trial
-
Dec 17, 2025, 14:29Sarah Richardson: Feeling So Proud to Be a Part of the Advocacy Team for the HFA
-
Dec 17, 2025, 06:28Wolfgang Miesbach on Linus Völker’s Presentation of Caplacizumab as Frontline Therapy for iTTP
-
Dec 17, 2025, 06:11Lisa Murphy Thanks Stroke Foundation Team for An Impactful, Rewarding and Incredible Year
-
Dec 17, 2025, 06:05Emmanuel J Favaloro Shares A Study on AI and Machine Learning in Thrombosis and Hemostasis
-
Dec 17, 2025, 05:54Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
-
Dec 17, 2025, 04:00Peter Verhamme on Genetic Predisposition to Thromboembolism and COVID